1 Min Read
Oct 19 (Reuters) -
* Crispr Therapeutics AG shares open at $15 in debut, above IPO price of $14 per share Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.